BioPorto A/S
BIOPOR.CO · CPH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.47 | 0.44 | -1.06 | 0.44 |
| FCF Yield | -13.35% | -7.41% | -6.89% | -9.46% |
| EV / EBITDA | -8.23 | -11.92 | -9.12 | -11.19 |
| Quality | ||||
| ROIC | -84.83% | -82.14% | -89.66% | -98.45% |
| Gross Margin | 67.68% | 65.19% | 65.73% | 62.01% |
| Cash Conversion Ratio | 1.11 | 0.98 | 0.64 | 0.99 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.75% | 8.48% | 7.68% | -3.06% |
| Free Cash Flow Growth | -51.24% | -4.79% | 18.49% | -75.04% |
| Safety | ||||
| Net Debt / EBITDA | 0.69 | 1.02 | 0.93 | 0.56 |
| Interest Coverage | -90.47 | -93.71 | -64.63 | -71.55 |
| Efficiency | ||||
| Inventory Turnover | 2.52 | 2.85 | 3.88 | 3.39 |
| Cash Conversion Cycle | 63.01 | -66.63 | -232.50 | 58.02 |